Advertisement

Advertisement

DE:7ZA Stock Latest News

Ascelia Pharma Calls 2026 AGM, Proposes No Dividend and New Incentive Plan

Company AnnouncementsAscelia Pharma Calls 2026 AGM, Proposes No Dividend and New Incentive Plan

Ascelia’s Liver Imaging Agent Orviglance Selected for Key ESGAR 2026 Presentation

PremiumCompany Announcements

Ascelia’s Liver Imaging Agent Orviglance Selected for Key ESGAR 2026 Presentation

9d ago

Ascelia Pharma’s Orviglance NDA Accepted by FDA as Cash Runway Extends Beyond 2026 Decision

PremiumCompany Announcements

Ascelia Pharma’s Orviglance NDA Accepted by FDA as Cash Runway Extends Beyond 2026 Decision

2M ago

Ascelia Pharma Deputy CEO and CFO Julie Waras Brogren to Depart for New CEO Role

PremiumCompany Announcements

Ascelia Pharma Deputy CEO and CFO Julie Waras Brogren to Depart for New CEO Role

2M ago

Ascelia Pharma Appoints Nomination Committee Ahead of 2026 AGM

PremiumCompany Announcements

Ascelia Pharma Appoints Nomination Committee Ahead of 2026 AGM

3M ago

Ascelia Pharma Adjusts Share Structure Following Share Saving Program

PremiumCompany AnnouncementsAscelia Pharma Adjusts Share Structure Following Share Saving Program

4M ago

Ascelia Pharma Converts Series C Shares to Ordinary Shares for Incentive Program

Company Announcements

Ascelia Pharma Converts Series C Shares to Ordinary Shares for Incentive Program

5M ago

FDA Accepts Ascelia Pharma’s Orviglance NDA for Review

Company Announcements

FDA Accepts Ascelia Pharma’s Orviglance NDA for Review

5M ago

Ascelia Pharma Files Patent for Orviglance, Enhancing Market Protection

PremiumCompany Announcements

Ascelia Pharma Files Patent for Orviglance, Enhancing Market Protection

5M ago

Ascelia Pharma Advances Orviglance with FDA Submission and Financial Strengthening

PremiumCompany Announcements

Ascelia Pharma Advances Orviglance with FDA Submission and Financial Strengthening

5M ago

Ascelia Pharma Strengthens Leadership Team for Future Growth

PremiumCompany Announcements

Ascelia Pharma Strengthens Leadership Team for Future Growth

5M ago

Ascelia Pharma Completes SEK 30 Million Directed Share Issue

PremiumCompany Announcements

Ascelia Pharma Completes SEK 30 Million Directed Share Issue

7M ago

Ascelia Pharma Plans SEK 30 Million Directed Share Issue

PremiumCompany AnnouncementsAscelia Pharma Plans SEK 30 Million Directed Share Issue

7M ago

Ascelia Pharma Submits NDA for Orviglance to FDA

Company Announcements

Ascelia Pharma Submits NDA for Orviglance to FDA

7M ago

Ascelia Pharma Converts Outstanding Convertibles, Extends Cash Runway

Company Announcements

Ascelia Pharma Converts Outstanding Convertibles, Extends Cash Runway

7M ago

Ascelia Pharma Nears NDA Submission for Orviglance

PremiumCompany Announcements

Ascelia Pharma Nears NDA Submission for Orviglance

8M ago

7ZA Earnings this Week: How Will it Perform?

PremiumPre-Earnings

7ZA Earnings this Week: How Will it Perform?

8M ago

Ascelia Pharma Nears Submission of Orviglance NDA to FDA

PremiumCompany Announcements

Ascelia Pharma Nears Submission of Orviglance NDA to FDA

8M ago

Ascelia Pharma Advances Orviglance Towards FDA Submission

PremiumCompany Announcements

Ascelia Pharma Advances Orviglance Towards FDA Submission

11M ago

Ascelia Pharma AB (7ZA) Q1 Earnings Cheat Sheet

PremiumPre-EarningsAscelia Pharma AB (7ZA) Q1 Earnings Cheat Sheet

11M ago

Ascelia Pharma’s AGM: Key Resolutions and Strategic Authorizations

Company Announcements

Ascelia Pharma’s AGM: Key Resolutions and Strategic Authorizations

11M ago

Is 7ZA a Buy, Before Earnings?

Pre-Earnings

Is 7ZA a Buy, Before Earnings?

1y ago

Trending

S&P 500

―

Dow Jones

―

Nasdaq 100

―

More Trending Stocks >